Zydus Lifesciences Ltd.

BSE: 532321 | NSE: ZYDUSLIFE

Mid Cap | Pharmaceuticals & Drugs

936.35

-6.20 (-0.66%)

< Home < Back

Zydus Lifesciences Ltd. News

>>

Zydus Lifesciences - Quaterly Results

>>

Zydus Lifesciences - Quaterly Results

>>

Zydus Lifesciences - Quaterly Results

>>

Zydus Lifesciences surges on getting USFDA’s final approval for Diltiazem Hydrochloride Tablets

>>

Zydus Lifesciences gets USFDA’s final approval for Diltiazem Hydrochloride Tablets

>>

Zydus Lifesciences gets NoC for ZDS-Varenicline Tablets 0.5 &1 mg

>>

Zydus Lifesciences rises as its arm completes acquisition of 85.6% equity shares of Amplitude Surgical SA

>>

Zydus Lifesciences’ arm completes acquisition of 85.6% equity shares of Amplitude Surgical SA

>>

Zydus Lifesciences inches up on getting USFDA’s tentative approval for Ibrutinib tablets

>>

Zydus Lifesciences gets USFDA’s tentative approval for Ibrutinib tablets

<< < 10 11 12 ...168 > >>